KK

Kristin Kennedy

Director, Finance at Candel Therapeutics

Kristin Kennedy, CPA has a solid work experience history with roles at Deloitte starting from an Audit Intern in 2012, moving up to Audit Associate, Audit Senior, and eventually becoming an Audit & Assurance Manager until 2019. Following that, they joined Akebia Therapeutics as an External Reporting and Technical Accounting Manager from 2019 to 2021. Kristin then transitioned to Gemini Therapeutics as a Senior Manager, Accounting, and later as an Associate Director, Accounting from 2021 to 2022. Currently, Kristin holds the position of Director, Finance at Candel Therapeutics starting from 2023.

Kristin Kennedy, CPA graduated from UNH Peter T. Paul College of Business and Economics in 2013 with a Bachelor's Degree in Accounting and Finance. In 2011, they also attended Corvinus University of Budapest, though it is unclear if a degree was obtained from there. Kristin obtained their Certified Public Accountant license from the Board of Accountancy in Massachusetts in July 2018.

Links

Previous companies

Deloitte logo
Akebia Therapeutics logo

Timeline

  • Director, Finance

    January, 2023 - present

View in org chart